{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T19:12:22Z","timestamp":1722453142335},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2009,11,1]]},"DOI":"10.2174\/187152709789541961","type":"journal-article","created":{"date-parts":[[2009,10,4]],"date-time":"2009-10-04T02:18:04Z","timestamp":1254622684000},"page":"353-362","source":"Crossref","is-referenced-by-count":8,"title":["Psychotropic Medications and the Treatment of Human Prion Diseases"],"prefix":"10.2174","volume":"8","author":[{"given":"Brian","family":"Appleby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/93557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T14:47:39Z","timestamp":1448290059000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-5273&volume=8&issue=5&spage=353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/187152709789541961","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11,1]]}}}